Correction to: IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2
J Clin Immunol
.
2021 Jan;41(1):28.
doi: 10.1007/s10875-021-00969-w.
Authors
Romain Lévy
1
2
3
,
Paul Bastard
4
5
6
,
Fanny Lanternier
5
7
,
Marc Lecuit
5
7
8
,
Shen-Ying Zhang
4
5
6
,
Jean-Laurent Casanova
4
5
6
9
Affiliations
1
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker Hospital for Sick Children, Paris, France.
[email protected]
.
2
University of Paris, Imagine Institute, Paris, France.
[email protected]
.
3
Immunology-Hematology and Rheumatology Unit, Necker Hospital for Sick Children, AP-HP, Paris, France.
[email protected]
.
4
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker Hospital for Sick Children, Paris, France.
5
University of Paris, Imagine Institute, Paris, France.
6
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
7
Necker Pasteur Center for Infectious Diseases and Tropical Medicine, Necker Hospital for Sick Children, AP-HP, Paris, France.
8
Biology of Infection Unit, Inserm U1117, Institut Pasteur, Paris, France.
9
Howard Hughes Medical Institute, New York, NY, 10065, USA.
PMID:
33474625
PMCID:
PMC7817072
DOI:
10.1007/s10875-021-00969-w
No abstract available
Publication types
Published Erratum